Cancer BiologybioRxiv
TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer
G. T. lee, W. T. Kim, Y. S. Kwon…·I. Y. Kim
This study identifies TCF4 as a driver of enzalutamide resistance in prostate cancer through neuroendocrine differentiation.
DOI 10.1371/journal.pone.0213488